OTCMKTS:OXBDF Oxford BioMedica (OXBDF) Stock Price, News & Analysis $6.00 0.00 (0.00%) As of 09/18/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and TrendsShort Interest About Oxford BioMedica Stock (OTCMKTS:OXBDF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Oxford BioMedica alerts:Sign Up Key Stats Today's Range$6.00▼$6.0050-Day Range$5.83▼$8.6552-Week Range$5.80▼$12.61VolumeN/AAverage Volume1,393 shsMarket Capitalization$635.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells. Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services. Oxford BioMedica has particular expertise in lentiviral vectors and also supports other vector platforms, including adeno-associated virus (AAV), for applications such as gene-modified cell therapies and in vivo gene therapies. Founded in 1995 and headquartered in Oxford, England, the company has expanded its operations through facilities and businesses in the United Kingdom, Europe, and the United States. Oxford BioMedica also has a history of developing its own gene-therapy candidates, although its primary strategic focus is providing specialized development and manufacturing services to biopharmaceutical partners. The company is led by Chief Executive Officer Frank Mathias.AI Generated. May Contain Errors. Read More Receive OXBDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioMedica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OXBDF Stock News HeadlinesOxford BioMedica (OXBDF) Gets a Hold from Deutsche BankSeptember 5, 2026 | theglobeandmail.comOxford BioMedica PLC OXBDFSeptember 2, 2026 | morningstar.comMTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.September 21 at 1:00 AM | Porter & Company (Ad)Oxford Biomedica Lists New Shares from Employee Incentive PlansAugust 14, 2026 | tipranks.comUK's Oxford Biomedica tumbles after annual revenue forecast cutAugust 7, 2026 | reuters.comOxford Biomedica trims 2026 outlook but leans on record client wins and growing pipelineAugust 7, 2026 | tipranks.comOxford Biomedica Expands Share Capital with New Employee Scheme AllotmentsJune 22, 2026 | tipranks.comJefferies Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)June 20, 2026 | theglobeandmail.comSee More Headlines OXBDF Stock Analysis - Frequently Asked Questions How have OXBDF shares performed this year? Oxford BioMedica's stock was trading at $8.15 at the beginning of 2026. Since then, OXBDF shares have decreased by 26.4% and is now trading at $5.9966. How do I buy shares of Oxford BioMedica? Shares of OXBDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/21/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:OXBDF Previous SymbolNASDAQ:OXBDF CIKN/A Webwww.oxfordbiomedica.co.uk Phone44-18-6578-3000FaxN/AEmployees891Year Founded1995Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$164.59 million Price / Sales3.86 Cash FlowN/A Price / Cash FlowN/A Book Value$0.62 per share Price / Book9.67Miscellaneous Outstanding Shares105,960,000Free FloatN/AMarket Cap$635.40 million OptionableNot Optionable Beta1.20 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:OXBDF) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioMedica Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioMedica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
